- Home
- WU vs VRDN Comparison
WU vs VRDN Comparison
Compare WU & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WU
- VRDN
- Stock Information
- Founded
- WU 1851
- VRDN 2006
- Country
- WU United States
- VRDN United States
- Employees
- WU N/A
- VRDN N/A
- Industry
- WU Business Services
- VRDN Medical Specialities
- Sector
- WU Consumer Discretionary
- VRDN Health Care
- Exchange
- WU Nasdaq
- VRDN Nasdaq
- Market Cap
- WU 2.6B
- VRDN 2.1B
- IPO Year
- WU 2006
- VRDN N/A
- Fundamental
- Price
- WU $9.09
- VRDN $27.27
- Analyst Decision
- WU Hold
- VRDN Strong Buy
- Analyst Count
- WU 10
- VRDN 11
- Target Price
- WU $8.56
- VRDN $39.60
- AVG Volume (30 Days)
- WU 12.0M
- VRDN 1.8M
- Earning Date
- WU 10-23-2025
- VRDN 11-05-2025
- Dividend Yield
- WU 10.33%
- VRDN N/A
- EPS Growth
- WU 18.91
- VRDN N/A
- EPS
- WU 2.32
- VRDN N/A
- Revenue
- WU $4,100,500,000.00
- VRDN $70,789,000.00
- Revenue This Year
- WU $0.08
- VRDN N/A
- Revenue Next Year
- WU $0.59
- VRDN $37,670.06
- P/E Ratio
- WU $3.93
- VRDN N/A
- Revenue Growth
- WU N/A
- VRDN 23340.07
- 52 Week Low
- WU $7.85
- VRDN $9.90
- 52 Week High
- WU $11.95
- VRDN $28.60
- Technical
- Relative Strength Index (RSI)
- WU 56.82
- VRDN 72.10
- Support Level
- WU $8.86
- VRDN $22.14
- Resistance Level
- WU $9.73
- VRDN $28.60
- Average True Range (ATR)
- WU 0.34
- VRDN 1.34
- MACD
- WU 0.02
- VRDN 0.33
- Stochastic Oscillator
- WU 57.76
- VRDN 81.01
About WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2024 and is the largest money transfer company in the world.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).